文献速递复苏、休克与脓毒症

三叉神经刺激:失血性休克复苏的新方法

Trigeminal Nerve Stimulation: A Novel Method of Resuscitation for Hemorrhagic Shock.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论大鼠重度失血性休克模型显示,无液体复苏时三叉神经刺激使60分钟生存率从0%提高到90%(p<0.001)。

该动物研究在大鼠中诱导重度失血性休克(平均动脉压先达27±1 mmHg并维持5分钟,再维持于27±2 mmHg共30分钟),随机分为对照组、溶媒组和三叉神经刺激组。在不进行液体复苏的条件下,三叉神经刺激组60分钟生存率为90%,对照组为0%(p<0.001)。三叉神经刺激通过心率变异性测得交感与副交感神经系统的强烈协同共激活,减轻交感神经过度活跃、提高副交感张力、延缓血流动力学失代偿、改善脑灌注,并产生交感介导的血压低频振荡、升高循环去甲肾上腺素水平、减轻全身炎症。作者认为三叉神经刺激通过调节自主神经激活内源性升压反应、改善脑灌注并减轻炎症,从而提高生存。

要点

  • 大鼠重度失血性休克(平均动脉压27±1 mmHg维持5分钟,再27±2 mmHg维持30分钟)不补液时,三叉神经刺激组60分钟生存率90%,对照组0%(p<0.001)。
  • 三叉神经刺激经心率变异性测得交感与副交感神经系统强烈协同共激活,减轻交感神经过度活跃并提高副交感张力。
  • 三叉神经刺激延缓血流动力学失代偿、改善脑灌注,并产生交感介导的血压低频振荡,与对中心性低血容量的耐受增加相关。
  • 三叉神经刺激升高循环去甲肾上腺素水平,与溶媒组相比减轻全身炎症。
  • 该研究为动物实验(雄性Sprague-Dawley大鼠),作者仅将其作为失血性休克的新型复苏策略进行探索。

适用人群与场景

  • 雄性Sprague-Dawley大鼠,重度失血性休克模型:放血至平均动脉压达27±1 mmHg并维持5分钟,随后维持于27±2 mmHg共30分钟。
  • 研究在不进行液体复苏的条件下分析三叉神经刺激的效果。

处置流程与药物剂量

  • 三叉神经刺激作为干预手段,在不进行液体复苏的条件下应用于重度失血性休克大鼠。
  • 研究未报告三叉神经刺激的具体刺激参数、给药方案或剂量。

研究设计与关键结果

  • 研究类型为动物实验;对象为雄性Sprague-Dawley大鼠;随机分为对照组、溶媒组和三叉神经刺激组。
  • 主要结局:60分钟生存率在三叉神经刺激组为90%,对照组为0%(p<0.001)。
  • 三叉神经刺激经心率变异性测得交感与副交感神经系统强烈协同共激活;不进行液体扩容时,三叉神经刺激减轻交感神经过度活跃并提高副交感张力,延缓血流动力学失代偿、改善脑灌注。
  • 三叉神经刺激产生交感介导的全身血压低频振荡,与对中心性低血容量的耐受增加相关,并升高循环去甲肾上腺素水平。
  • 与溶媒组相比,三叉神经刺激减轻全身炎症。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠重度失血性休克模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文据此未给出临床推荐;作者认为三叉神经刺激通过调节交感和副交感神经活动,激活内源性升压反应、改善脑灌注并减轻炎症,从而提高生存。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine if trigeminal nerve stimulation can ameliorate the consequences of acute blood loss and improve survival after severe hemorrhagic shock.

DESIGN: Animal study.

SETTING: University research laboratory.

SUBJECTS: Male Sprague-Dawley rats.

INTERVENTIONS: Severe hemorrhagic shock was induced in rats by withdrawing blood until the mean arterial blood pressure reached 27 ± 1 mm Hg for the first 5 minutes and then maintained at 27 ± 2 mm Hg for 30 minutes. The rats were randomly assigned to either control, vehicle, or trigeminal nerve stimulation treatment groups. The effects of trigeminal nerve stimulation on survival rate, autonomic nervous system activity, hemodynamics, brain perfusion, catecholamine release, and systemic inflammation after severe hemorrhagic shock in the absence of fluid resuscitation were analyzed.

MEASUREMENTS AND MAIN RESULTS: Trigeminal nerve stimulation significantly increased the short-term survival of rats following severe hemorrhagic shock in the absence of fluid resuscitation. The survival rate at 60 minutes was 90% in trigeminal nerve stimulation treatment group whereas 0% in control group (p < 0.001). Trigeminal nerve stimulation elicited strong synergistic coactivation of the sympathetic and parasympathetic nervous system as measured by heart rate variability. Without volume expansion with fluid resuscitation, trigeminal nerve stimulation significantly attenuated sympathetic hyperactivity paralleled by increase in parasympathetic tone, delayed hemodynamic decompensation, and improved brain perfusion following severe hemorrhagic shock. Furthermore, trigeminal nerve stimulation generated sympathetically mediated low-frequency oscillatory patterns of systemic blood pressure associated with an increased tolerance to central hypovolemia and increased levels of circulating norepinephrine levels. Trigeminal nerve stimulation also decreased systemic inflammation compared with the vehicle.

CONCLUSIONS: Trigeminal nerve stimulation was explored as a novel resuscitation strategy in an animal model of hemorrhagic shock. The results of this study showed that the stimulation of trigeminal nerve modulates both sympathetic and parasympathetic nervous system activity to activate an endogenous pressor response, improve cerebral perfusion, and decrease inflammation, thereby improving survival.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Li C, Chiluwal A, Afridi A, et al. Trigeminal Nerve Stimulation: A Novel Method of Resuscitation for Hemorrhagic Shock. Crit Care Med. 2019. PMID: 30889027. doi:10.1097/CCM.0000000000003735

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。